BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7656696)

  • 1. [The expressions of proliferating cell nuclear antigen (PCNA) in primary gallbladder carcinoma and its significance].
    Qing D; Xia L; Zhang X
    Zhonghua Wai Ke Za Zhi; 1995 Feb; 33(2):102-4. PubMed ID: 7656696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The expression and significance of proliferating cell nuclear antigen/cyclin in cholangiocarcinoma and gallbladder carcinoma].
    Yang Z; Zhong D; Li Y
    Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):437-8. PubMed ID: 8565737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.
    Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S
    Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS
    Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
    Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA.
    Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Miwa A
    Hepatogastroenterology; 1999; 46(27):1959-62. PubMed ID: 10430377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the proliferative cell nuclear antigen (PCNA) in adenocarcinoma of the gallbladder, and its relationship to prognosis.
    Hanada K; Itoh M; Fujii K; Tsuchida A; Ishimaru S; Hirata M; Kajiyama G
    Scand J Clin Lab Invest; 1995 Aug; 55(5):377-82. PubMed ID: 8545595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
    Griffey SM; Kraegel SA; Madewell BR
    J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma.
    Xu LN; Zou SQ; Wang JM
    World J Gastroenterol; 2005 Jun; 11(24):3719-23. PubMed ID: 15968727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferating patterns of salivary gland adenocarcinomas with the use of PCNA labeling.
    Zhao M; Zhao QX; Saitoh M; Ohmura H; Okamoto Y; Shrestha P; Mori M
    Anticancer Res; 1996; 16(5A):2693-8. PubMed ID: 8917372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of p53 and proliferating cell nuclear antigen in malignant tumor of maxillary sinus].
    Xie RH; Chen ZH; Chen MY; Hou JH; Wu JH; Wu GH; Wu QL
    Ai Zheng; 2002 Nov; 21(11):1244-7. PubMed ID: 12526226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
    Xu YJ
    Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proliferating cell nuclear antigen (PCNA/cyclin) in gastric carcinoma in relation to its prognosis].
    Li N
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):34-6. PubMed ID: 8101481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating cell nuclear antigen immunostaining in breast carcinoma and its relationship to clinical and pathological variables.
    Agarwal S; Jain R; Rusia U; Gupta RL
    Indian J Pathol Microbiol; 1997 Jan; 40(1):11-6. PubMed ID: 9145605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of proliferating cell nuclear antigen (PCNA) index and microvessel density (MVD) in endometrial carcinoma].
    Xiao L; Tang LD
    Ai Zheng; 2005 Jan; 24(1):19-22. PubMed ID: 15642194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
    Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between immunohistochemical evaluation of thymidylate synthase and proliferating cell nuclear antigen labeling index in gastrointestinal carcinoma.
    Kunimoto Y; Nakamura T; Ohno M; Kuroda Y
    Oncol Rep; 2004 Dec; 12(6):1163-7. PubMed ID: 15547732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer.
    Dang CX; Han Y; Qin ZY; Wang YJ
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):302-5. PubMed ID: 14612290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.